TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 21 filers reported holding TRINITY BIOTECH PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $25,740 | -44.0% | 26,000 | -39.7% | 0.00% | – |
| Q3 2022 | $46,000 | -23.3% | 43,100 | -11.6% | 0.00% | – |
| Q2 2022 | $60,000 | -44.4% | 48,750 | -52.1% | 0.00% | – |
| Q1 2022 | $108,000 | -29.4% | 101,673 | -5.0% | 0.00% | – |
| Q4 2021 | $153,000 | -20.3% | 106,973 | +20.1% | 0.00% | – |
| Q3 2021 | $192,000 | +8.5% | 89,073 | +48.3% | 0.00% | – |
| Q2 2021 | $177,000 | +113.3% | 60,073 | +171.5% | 0.00% | – |
| Q1 2021 | $83,000 | -76.4% | 22,123 | +21.0% | 0.00% | -100.0% |
| Q1 2015 | $352,000 | -53.4% | 18,288 | -44.3% | 0.00% | -50.0% |
| Q2 2014 | $756,000 | +170.0% | 32,831 | +194.3% | 0.00% | +100.0% |
| Q4 2013 | $280,000 | -13.0% | 11,156 | -22.0% | 0.00% | 0.0% |
| Q3 2013 | $322,000 | +24.3% | 14,306 | -6.8% | 0.00% | 0.0% |
| Q2 2013 | $259,000 | – | 15,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 739,669 | $13,514,000 | 6.33% |
| ACK Asset Management | 749,867 | $13,700,000 | 4.92% |
| CASTLEROCK ASSET MANAGEMENT INC | 26,751 | $489,000 | 4.12% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,297 | $5,651,000 | 2.83% |
| Paradice Investment Management LLC | 348,686 | $6,370,000 | 1.66% |
| Park West Asset Management LLC | 600,770 | $10,976,000 | 1.62% |
| Adirondack Research & Management Inc. | 220,638 | $4,031,000 | 1.50% |
| RK Capital | 375,043 | $6,852,000 | 1.40% |
| KEANE CAPITAL MANAGEMENT INC | 70,000 | $1,279,000 | 1.23% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 953,618 | $17,423,000 | 1.08% |